IWM
RMD icon

Inlight Wealth Management’s ResMed RMD Stock Holding History

Inlight Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$5.54K – 181
2025
Q4 		$5.54K Hold
23
– – ﹤0.01% 173
2025
Q3 		$6.3K Hold
23
– – ﹤0.01% 178
2025
Q2 		$5.93K Hold
23
– – ﹤0.01% 178
2025
Q1 		$5.15K Buy
+23
New +$5.37K ﹤0.01% 197

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Inlight Wealth Management's RMD Position: Q1 2026 in Review

Inlight Wealth Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 23 shares — an estimated $5.54K sold.

Inlight Wealth Management first reported a position in RMD in Q1 2025 and held it in 4 quarters. The position peaked at $6.3K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Inlight Wealth Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Inlight Wealth Management sold 23 ResMed shares in Q1 2026, an estimated $5.54K.
  • Inlight Wealth Management first reported a position in ResMed in Q1 2025 and held it in 4 quarters.
  • Inlight Wealth Management's ResMed position peaked at $6.3K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Inlight Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.